Search or
𝛼SK
𝛼SKSign in with Google. Opens in new tab
bullish
Legend Biotech (传奇生物) IPO Trading: +27% Upside from Pricing
471 Views05 Jun 2020 08:20
Legend Biotech, a leading CAR-T player, priced at USD 23/ADS and raised USD 423 million. The stock will start trading today. In this note, we will...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Taiwan Top 50 ETF Rebalance Preview: Another Inclusion for King Slide
- [Japan M&A] Minebea Matches YAGEO for Shibaura Elec (6957) At ¥6,200. Presses on Early Cashout
- [Japan M&A] Founder, KEPCO, Try ¥2,750 Bain-Led MBO on Rezil (176A). Light Given Growth - Bumpity?
- Shengjing Bank (2066 HK): Another Rural Commercial Bank Delisting
- HMM: Tender Offer of 8% of Outstanding Shares and Cancellation
Top Unpaywalled Insights
More »- [IO Technicals 2025/33] China Woes Deepen, Bearish Momentum Grips Iron Ore
- Tradesmen's Collective: Fixing the Trades with Tech, Transparency & Boots-on-the-Ground
- VEON 2Q25: Solid Digital Non-Telco Products Uplift, Kyivstar Listing in Focus
- [IO Technicals 2025/32] Bullish Momentum Builds
- Grab Holdings (GRAB US) - Harvesting Sequentially
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Legend Biotech Follow-On - A Little Opportunistic. Last Deal Did Well, After a Large Correction26 Jul 2022
- Legend Biotech (传奇生物) Follow-On Offering - Untimely Raise15 Dec 2021
- Legend Biotech (传奇生物) IPO Trading: +27% Upside from Pricing05 Jun 2020
- Legend Biotech (传奇生物) Pre-IPO: A Good Deal for the Promising CAR-T01 Jun 2020
- Legend Biotech (传奇生物) Pre-IPO: Superior Efficacy Vs Bluebird/BMS Candidate26 May 2020
x